Huntington National Bank’s Olema Pharmaceuticals OLMA Stock Holding History

Huntington National Bank’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15	Hold	1	–	–	﹤0.01%	3611
2025 Q4	$25	Hold	1	–	–	﹤0.01%	3263
2025 Q3	$10	Hold	1	–	–	﹤0.01%	3711
2025 Q2	$4	Sell	1 -625	-100%	-$2.79K	﹤0.01%	3901
2025 Q1	$2.35K	Sell	626 -20	-3%	-$101	﹤0.01%	2184
2024 Q4	$3.77K	Buy	646 +35	+6%	+$350	﹤0.01%	2087
2024 Q3	$7.29K	Sell	611 -33	-5%	-$422	﹤0.01%	1874
2024 Q2	$6.97K	Buy	+644	New	+$6.98K	﹤0.01%	1817

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Huntington National Bank's OLMA Position: Q1 2026 in Review

Huntington National Bank held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 1 share worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #3611.

Huntington National Bank first reported a position in OLMA in Q2 2024 and has held it in 8 quarters since. The position peaked at $7.29K in Q3 2024. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

Huntington National Bank held 1 share of Olema Pharmaceuticals worth $15 as of Q1 2026.
Huntington National Bank left its Olema Pharmaceuticals share count unchanged in Q1 2026.
Olema Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3611 holding.
Huntington National Bank first reported a position in Olema Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Huntington National Bank's Olema Pharmaceuticals position peaked at $7.29K in Q3 2024.
195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.